Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...
The changes will start in just two weeks, with recipients as well as a raft of businesses told they will need to be aware.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback